Mohammad Zagzoog, MD1, Wisam Jamal, MD2, Salma Sait3, Ashraf Maghrabi, MD3. 1King Abdulaziz Medical city, 2University of Jeddah, 3King Abdullaziz University
Introduction: One anastomosis gastric bypass (OAGB) is an emerging bariatric procedure, which has been reported to be safe and effective. This study aims to evaluate the short-term outcome of OAGB and its mid-term effects on weight loss and remission of Type 2 Diabetes Mellitus (T2DM).
Methods: A retrospective review of patients who had undergone OAGB between January 2013 and January 2016 in King Abdulaziz University Hospital, Jeddah, Saudi Arabia is presented here. Patients; perioperative characteristics, biochemical profile (HbA1c and iron) and details on subsequent weight loss in terms of Body Mass Index (BMI) and Excess Weight Loss percentage (%EWL) along with early and late postoperative complications were evaluated.
Results: Out of the forty-three patients who underwent OAGB, 38 were included in this study and completed the 2-years follow up. Average operative time was 107.5±21.8 min and average length of hospital stay was 2.5 ± 0.64 day. Mean preoperative BMI was 48.6±9 kg/m2and at 1 and 2 years of follow up was 30.6±8.7 and 27.5±6.3, respectively. No mortality, anastomotic leak or bleeding were reported. Most common mid-term complication was iron deficiency anemia (n=7/38). Remission of T2DM at 6 month was 81.8%. Patients with preoperative T2DM for less than 10 years showed better remission (p =0.024).
Conclusion: Our analysis suggests that OAGB is a safe and effective weight loss procedure that carries low perioperative risk and acceptable nutritional complications in the midterm, with a notable remission of T2DM. Preoperative duration of T2DM plays a major role in achieving remission after OAGB.
Presented at the SAGES 2017 Annual Meeting in Houston, TX.
Abstract ID: 94812
Program Number: P137
Presentation Session: Poster Session (Non CME)
Presentation Type: Poster